An interesting point would be the use of the same dose range in BPC 157 studies [1,2,3,4,5,6,7,8,9,10,11]
This makes it hard to draw firm conclusions about knee outcomes such as pain, function, or return to activity
Reports often mention reduced muscle tightness, less joint discomfort after high-volume days, and an overall quicker bounce-back between sessions
Standard reconstitution involves adding 2 mL of bacteriostatic water to a 5 mg vial, yielding a concentration of 2.5 mg/mL (2,500 mcg/mL)
BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats